ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      87.07
      0.18%
      Bitcoin
      57,246.71
      -4.85%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Cellectis Nom Eo 05 (ALCLS) Quote

      Cellectis Nom Eo 05

      Cellectis Nom Eo 05 (ALCLS)

      EU
      1.822
      0.008
      ( 0.44% )
      Updated: 10:25:02
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.822
      Bid
      1.82
      Ask
      1.836
      Volume
      69,557
      1.816 Day's Range 1.894
      0.888 52 Week Range 3.44
      Market Cap
      116.522M
      Previous Close
      1.814
      Open
      1.838
      Last Trade
      120
      @
      1.822
      Last Trade Time
      10:18:20
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      105,120
      Shares Outstanding
      45,874,895
      Dividend Yield
      -
      PE Ratio
      -1.15
      Earnings Per Share (EPS)
      -2.2
      Revenue
      9.2M
      Net Profit
      -101.06M

      About Cellectis Nom Eo 05

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.cellectis.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1970
      Cellectis Nom Eo 05 is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 1.81 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 0.888 € to 3.44 €.

      Cellectis Nom Eo 05 currently has 45,874,895 shares outstanding. The market capitalization of Cellectis Nom Eo 05 is 116.52 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -1.15.

      ALCLS Latest News

      More News

      Résultats de l’Assemblée Générale Mixte de Cellectis du 28 juin 2024

      Résultats de l’Assemblée Générale Mixte de Cellectis du 28 juin 2024 NEW YORK, 28 juin 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de...

      June 28 2024
      GlobeNewswire Inc.

      Cellectis publie un article scientifique dévoilant trois facteurs clés pour une édition efficace avec des TALE base editors

      Cellectis publie un article scientifique dévoilant trois facteurs clés pour une édition efficace avec des TALE base editors NEW YORK, 20 juin 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext...

      June 20 2024
      GlobeNewswire Inc.

      Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

      NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ:  CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...

      June 12 2024
      GlobeNewswire Inc.

      Monthly information on share capital and company voting rights

      Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority) PARIS, June 05, 2024 (GLOBE NEWSWIRE...

      June 05 2024
      GlobeNewswire Inc.

      Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

      Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS...

      June 05 2024
      GlobeNewswire Inc.

      Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia

      Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Cellectis...

      June 04 2024
      GlobeNewswire Inc.

      Cellectis obtient la désignation de médicament orphelin pour son produit CAR T allogénique UCART22 pour les patients atteints de leucémie lymphoblastique aiguë

      Cellectis obtient la désignation de médicament orphelin pour son produit CAR T allogénique UCART22 pour les patients atteints de leucémie lymphoblastique aiguë NEW YORK, 04 juin 2024 (GLOBE...

      June 04 2024
      GlobeNewswire Inc.

      L’ Assemblée Générale Mixte de Cellectis se tiendra le 28 juin 2024

      L’ Assemblée Générale Mixte de Cellectis se tiendra le 28 juin 2024 NEW YORK, 29 mai 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie...

      May 29 2024
      GlobeNewswire Inc.

      Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024

      NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...

      May 29 2024
      GlobeNewswire Inc.

      Cellectis publie ses résultats financiers du premier trimestre 2024

      Cellectis publie ses résultats financiers du premier trimestre 2024 •  Cellectis annonce la réalisation de l’investissement additionnel d’AstraZeneca •  Situation de trésorerie de 143...

      May 28 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.1529.101796407191.671.8941.634610011.72293929DE
      4-0.568-23.76569037662.392.391.6341096861.87330208DE
      12-0.788-30.19157088122.613.0251.6341051202.36341015DE
      26-0.966-34.64849354382.7883.0251.6341027702.44441189DE
      52-0.029-1.566720691521.8513.440.8881807292.46178956DE
      156-10.928-85.709803921612.7513.220.8881688203.54310427DE
      260-12.078-86.892086330913.928.450.8881419806.84247669DE

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KOSSKoss Corporation
      $ 10.63
      (143.81%)
      		70.06M
      JEWLAdamas One Corporation
      $ 0.4615
      (89.14%)
      		6.58M
      VVPRVivoPower International PLC
      $ 2.50
      (66.67%)
      		55.79M
      DOYUDouYu International Holdings Ltd
      $ 17.94
      (42.49%)
      		5.25M
      AHGAkso Health Group
      $ 1.155
      (40.51%)
      		520k
      SHPWShapeways Holdings Inc
      $ 0.2693
      (-61.86%)
      		1.99M
      SONMSonim Technologies Inc
      $ 0.5507
      (-42.34%)
      		1.47M
      SHOTWSafety Shot Inc
      $ 0.18
      (-35.71%)
      		2.01k
      AMIXAutonomix Medical Inc
      $ 0.6415
      (-31.76%)
      		19.59M
      VIVKVivakor Inc
      $ 2.31
      (-31.66%)
      		368.29k
      NVDANVIDIA Corporation
      $ 128.28
      (4.57%)
      		215.8M
      ZCARZoomcar Holdings Inc
      $ 0.183
      (33.97%)
      		204.3M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.1736
      (-3.50%)
      		202.28M
      TSLATesla Inc
      $ 246.39
      (6.54%)
      		166.56M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 14.02
      (13.16%)
      		86.38M

      Discussion

      View Full Feed
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 minutes ago
      Neat drink design
      VGID
      PROPHET-of-PROFITS PROPHET-of-PROFITS 3 minutes ago
      Any news and this goes 015 at least.
      EMGE
      Slojab Slojab 3 minutes ago
      Why do say it's irrelevant? Sumcoin is listed as their most valuable asset. To me, that makes it extremely relevant.
      BMCS
      Puma31 Puma31 3 minutes ago
      Oh but they are selling, pumpkin

      Here are some of the installs

      https://www.passiveportal.com/gallery#conference
      VXIT
      TRUSTUNITS1000000 TRUSTUNITS1000000 3 minutes ago
      A lot of inventory
      BullNBear52 BullNBear52 3 minutes ago
      Your whole post below is pretty much BS since you have zero understanding of ADHD. First ritalin is not a substitute for Adderall and no doctor would prescribe it.

      The increase in Adderall scripts is due to HS, college and professional athletes claiming they have ADHD when in fact th
      glenn1919 glenn1919 3 minutes ago
      PLUG.....UP........TELL.....FCEL.......https://stockcharts.com/h-sc/ui?s=PLUG&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=UP&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=TELL&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=FCEL&p=
      FCEL
      MetaMonster MetaMonster 4 minutes ago
      We will not faulter we will not fail, wears going to send these shorts to hell where they belong
      RNAZ
      TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
      Anyone buy recently
      TGGI
      Chartmaster Chartmaster 4 minutes ago
      Chart shows yesterday's fluke buying OP open, and usually these fluke opens mark the low for big rally, .0053 will NOT be breached now and gap got filled quickly shows the massive MOMENTUM!!!
      https://investorshub.advfn.com/uimage/uploads/2024/7/3/sqxjdNSAV_7-3-24.PNG

      And this w
      NSAV
      TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
      Management make us happy
      TGGI
      TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
      They should have rolled in a company 400,000,000 ???????
      DMDD
      gshores gshores 5 minutes ago
      It does confirm that John park is a man of his word! He got it done and this massive business venture continues to accelerate! We longs are in for a ride of our lives, would hate to be short on this one!
      Bullish as the day is long.
      SPZI
      magicnite magicnite 5 minutes ago
      if below 14 right to 1 JMO
      SHIBUSD
      TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
      Maybe comes back
      DMDD
      TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
      Shareholders post
      DMDD
      TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
      Would make a great reverse merger
      DMDD
      Money hunt Money hunt 6 minutes ago
      RNAZ 4th of July Cancer Breakthrough In the United states of america Hell yes!!!
      RNAZ
      glenn1919 glenn1919 7 minutes ago
      CHPT......BLNK.......FREY.......EVGO.......https://stockcharts.com/h-sc/ui?s=CHPT&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=BLNK&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=FREY&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=E
      BLNK CHPT EVGO
      energy_wave energy_wave 7 minutes ago
      I guess you can un pin that sticky note at the top of the list. It's irreverent.

      Better off looking into Covo coin.
      BMCS
      BBANBOB BBANBOB 7 minutes ago
      HOPE THIS IS CORRECT FRED

      ..$20 PER...........checks in the mail...............cred...........
      Monksdream Monksdream 7 minutes ago
      TTNP under $10
      https://investorshub.advfn.com/uimage/uploads/2024/7/4/fwieuIMG_9220.gif
      TTNP
      TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
      Getting interesting
      AABB
      getmoreshares getmoreshares 7 minutes ago
      Gov protecting us from ourselves!
      chainma1l chainma1l 7 minutes ago
      Another subpenny that is now going to cure cancer.
      Back to pump and dump status with Identa.
      4th of July meeting was to keep people from watching.
      Shady.
      IDTA

      Your Recent History

      EU
      ALCLS
      Cellectis Nom Eo 05
      Delayed Upgrade Clock